Versor Investments LP Makes New Investment in American Well Co. (NYSE:AMWL)

Versor Investments LP purchased a new position in American Well Co. (NYSE:AMWLFree Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 251,000 shares of the company’s stock, valued at approximately $294,000. Versor Investments LP owned about 0.09% of American Well at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. LPL Financial LLC purchased a new position in American Well in the second quarter worth $32,000. Point72 Middle East FZE purchased a new stake in shares of American Well during the fourth quarter valued at $33,000. Point72 Hong Kong Ltd grew its holdings in shares of American Well by 175.1% during the first quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company’s stock valued at $34,000 after buying an additional 5,147 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of American Well by 153.6% during the second quarter. Allspring Global Investments Holdings LLC now owns 16,568 shares of the company’s stock valued at $35,000 after buying an additional 10,036 shares during the last quarter. Finally, Private Advisor Group LLC purchased a new stake in shares of American Well during the first quarter valued at $35,000. 49.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at American Well

In related news, CFO Robert Shepardson sold 24,990 shares of the business’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $1.26, for a total transaction of $31,487.40. Following the completion of the transaction, the chief financial officer now directly owns 1,001,130 shares in the company, valued at $1,261,423.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other American Well news, CFO Robert Shepardson sold 24,990 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $1.26, for a total value of $31,487.40. Following the completion of the transaction, the chief financial officer now owns 1,001,130 shares in the company, valued at $1,261,423.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Vukasin Paunovich sold 58,409 shares of the company’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $1.07, for a total transaction of $62,497.63. Following the completion of the transaction, the executive vice president now owns 615,312 shares of the company’s stock, valued at approximately $658,383.84. The disclosure for this sale can be found here. Insiders sold 133,078 shares of company stock worth $161,339 over the last three months. Company insiders own 12.94% of the company’s stock.

American Well Price Performance

NYSE AMWL opened at $1.06 on Thursday. The company has a market capitalization of $303.39 million, a PE ratio of -0.43 and a beta of 1.03. The company has a fifty day moving average of $1.26 and a 200 day moving average of $1.37. American Well Co. has a 1 year low of $0.93 and a 1 year high of $4.28.

American Well (NYSE:AMWLGet Free Report) last posted its earnings results on Wednesday, November 1st. The company reported ($0.20) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.20). The company had revenue of $61.92 million during the quarter, compared to the consensus estimate of $62.89 million. American Well had a negative net margin of 257.20% and a negative return on equity of 33.76%. Research analysts expect that American Well Co. will post -0.84 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Morgan Stanley dropped their price objective on shares of American Well from $2.50 to $1.75 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $3.63.

Get Our Latest Report on American Well

American Well Company Profile

(Free Report)

American Well Corporation operates digital care delivery enablement platform in the United States and internationally. Its platform connects and enables providers, insurers, patients, and innovators to deliver access for quality care. The company's products offer urgent care; scheduled visits; acute behavioral health; telestroke; comprehensive behavioral health; ED triage; pediatrics; end-stage renal disease and dialysis; and retail health, school health, and home settings.

Featured Stories

Want to see what other hedge funds are holding AMWL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Well Co. (NYSE:AMWLFree Report).

Institutional Ownership by Quarter for American Well (NYSE:AMWL)

Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.